학술논문
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease
Document Type
Article
Author
Source
In: Breast Cancer Research . (Breast Cancer Research, December 2023, 25(1))
Subject
Language
English
ISSN
1465542X
14655411
14655411